查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654674

全球預防保健技術與服務市場 - 2025 年至 2033 年

Global Preventive Healthcare Technologies and Services Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球預防醫療技術和服務市場規模達到 2,652.9 億美元，預計到 2033 年將達到 7,815.1 億美元，2025-2033 年預測期內的複合年成長率為 12.2%。

預防性醫療保健技術和服務是當代醫療保健系統的重要組成部分，強調預防疾病和有效管理健康狀況的主動策略。該過程涉及利用診斷工具在疾病出現症狀之前識別疾病。診斷影像、基因檢測和生物標記檢測等技術對於早期發現癌症和心血管疾病等病症至關重要，可顯著提高治療成功率和存活結果。

疫苗透過訓練免疫系統識別和對抗病原體對於預防傳染病至關重要。預防性疫苗和治療性疫苗的接種對於控制疾病爆發和降低盛行率的公共衛生措施至關重要。針對糖尿病、高血壓和心臟病等慢性病的有效管理策略至關重要。這包括透過遠距醫療服務、遠端監控工具和行動醫療應用程式進行的定期監測，以支援患者遵守治療計劃並保持整體健康。

人工智慧（AI）和穿戴式裝置等創新技術的結合，實現了即時健康監測，增強了預防保健。這些工具可以追蹤生命徵象、體力活動和其他健康指標，為醫療保健提供者提供潛在風險在升級為嚴重問題之前的寶貴見解。這些因素推動了全球預防醫療技術和服務市場的擴張。

市場動態：

促進因素與約束因素

醫療科技創新

醫療技術的創新是全球預防醫療技術和服務市場成長的關鍵驅動力。這些進步從根本上改變了醫療保健服務，將重點從被動治療轉向主動預防。

人工智慧技術正在透過分析大量資料集來識別模式和預測健康風險，從而徹底改變診斷和治療計劃。例如，人工智慧演算法可以非常精確地檢測出癌症等疾病的早期跡象，使醫療保健提供者能夠在病情惡化之前採取預防措施。此外，人工智慧簡化了管理任務，使醫療專業人員能夠更加專注於患者護理。遠距醫療平台中人工智慧診斷工具的整合提高了準確性和效率，促進了更具預防性的護理方法。

穿戴式裝置已經取得了顯著的進步，可以持續監測心率和血糖水平等各種健康指標。這些設備有助於及早發現潛在問題，使個人能夠掌控自己的健康，這對於及時介入至關重要。穿戴式裝置與醫療保健系統的結合可以實現即時資料共享，增強個人化護理。

醫療技術的創新對於推動全球預防性醫療技術和服務市場的發展至關重要，它可以增強醫療服務的機會、提高診斷準確性、透過穿戴式裝置增強患者能力、並透過人工智慧和預測分析促進個人化介入。這些發展代表了一種變革性的健康管理方法，該方法優先考慮預防和主動護理策略。

此外，行業主要參與者的創新發布和政府舉措將推動全球預防醫療技術和服務市場的成長。例如，2024 年 12 月，富士醫療與 Dr. Kutty's Healthcare 的合資企業 NURA 在喀拉拉邦卡利卡特推出了首家由人工智慧驅動的健康篩檢中心。該設施標誌著 NURA 向印度醫療保健市場戰略擴張邁出的重要一步，旨在提高早期疾病檢測能力。該中心每天最多可篩檢 50 人，專注於檢測癌症和代謝症候群，並計劃在未來篩檢運動症候群。

此外，2024年11月，富士通宣布開發Policy Twin，這是一項創新的數位孿生技術，旨在模擬地方政府政策的社會影響。這項創新工具旨在透過提供數據驅動的見解，使政策制定者能夠最佳化決策，從而提高市政預防性醫療服務的有效性。所有這些因素都要求全球預防醫療技術和服務市場。此外，對數位健康解決方案擴展的需求不斷成長，促進了全球預防醫療技術和服務市場的擴張。

資料安全和隱私問題

資料安全和隱私問題將阻礙全球預防醫療技術和服務市場的成長。隨著預防性醫療保健越來越依賴數位平台進行個人化護理，對資料安全和病患隱私的擔憂顯著加劇。依賴科技收集和分享敏感病患資訊引發了對未經授權的存取、資料外洩和侵犯隱私的擔憂。這種日益成長的擔憂導致消費者對醫療保健組織保護其資料的能力產生明顯的不信任，這可能會阻止個人使用預防性醫療保健服務。

例如，根據 HIPAA Journal 的資料，2024 年醫療保健產業的資料外洩事件大幅增加，共發生 13 起事件，每起事件涉及超過 100 萬筆醫療記錄。在這些事件中，Change Healthcare 資料外洩事件成為史上最大的醫療保健資料外洩事件，影響了近 1.9 億人。這起事件凸顯了醫療保健資料安全的嚴重漏洞，並強調了該領域網路攻擊的威脅日益升級。因此，上述因素可能會限制全球預防醫療技術和服務市場的潛在成長。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 醫療科技創新
    • 限制
      • 資料安全和隱私問題
    • 機會
    • 影響分析

第5章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 專利分析
  • 監管分析
  • SWOT 分析
  • 未滿足的需求

第 6 章：按技術類型

  • 早期檢測與篩檢技術
    • 診斷影像
    • 基因檢測
    • 生物標記檢測
    • 其他
  • 慢性病管理技術
    • 遠距醫療服務
    • 遠端監控工具
    • 行動健康應用程式
    • 其他
  • 疫苗
    • 預防疫苗
    • 治療性疫苗
  • 先進技術
    • 臨床決策支援系統 (CDSS)
    • 藥物管理系統
    • 電子健康紀錄 (EHR) 系統
    • 其他

第 7 章：按服務類型

  • 健康計劃
  • 診斷服務
  • 病人教育服務
  • 其他

第 8 章：按應用

  • 癌症預防與篩檢
  • 傳染病預防
  • 心血管疾病管理
  • 糖尿病管理
  • 其他

第 9 章：按最終用戶

  • 醫療保健提供者
  • 醫療保健付款人
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • Medtronic
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Myriad Genetics, Inc.
  • Abbott.
  • Quest Diagnostics.
  • Merck & Co., Inc.,
  • GSK plc.
  • Omnicell
  • McKesson Corporation
  • OMRON Healthcare
  • Pfizer Inc.
  • Sanofi

第 13 章：附錄

簡介目錄
Product Code: PH9109

The global preventive healthcare technologies and services market reached US$ 265.29 billion in 2024 and is expected to reach US$ 781.51 billion by 2033, growing at a CAGR of 12.2% during the forecast period 2025-2033.

Preventive healthcare technologies and services are crucial elements of contemporary healthcare systems, emphasizing proactive strategies to prevent diseases and effectively manage health conditions. This process involves utilizing diagnostic tools to identify diseases before they manifest symptoms. Techniques such as diagnostic imaging, genetic testing, and biomarker testing are vital for early detection of conditions like cancer and cardiovascular diseases, significantly enhancing treatment success rates and survival outcomes.

Vaccines are essential for preventing infectious diseases by training the immune system to recognize and combat pathogens. The administration of both preventive vaccines and therapeutic vaccines is fundamental to public health initiatives focused on controlling disease outbreaks and reducing prevalence. Effective management strategies for chronic conditions such as diabetes, hypertension, and heart disease are critical. This includes regular monitoring facilitated by telehealth services, remote monitoring tools, and mobile health applications, which support patients in adhering to treatment plans and maintaining their overall health.

The incorporation of innovative technologies, including artificial intelligence (AI) and wearable devices, enhances preventive care by enabling real-time health monitoring. These tools track vital signs, physical activity, and other health metrics, providing healthcare providers with valuable insights into potential risks before they escalate into serious issues. These factors have driven the global preventive healthcare technologies and services market expansion.

Market Dynamics: Drivers & Restraints

Innovations in Healthcare Technology

Innovations in healthcare technology are a critical driver of growth in the global preventive healthcare technologies and services market. These advancements are fundamentally transforming healthcare delivery, shifting the focus from reactive treatment to proactive prevention.

AI technologies are revolutionizing diagnostics and treatment planning by analyzing vast datasets to identify patterns and predict health risks. For instance, AI algorithms can detect early signs of diseases such as cancer with remarkable precision, enabling healthcare providers to implement preventive measures before conditions worsen. Additionally, AI streamlines administrative tasks, allowing healthcare professionals to focus more on patient care. The integration of AI-driven diagnostic tools within telehealth platforms enhances both accuracy and efficiency, promoting a more preventive approach to care.

Wearable devices have significantly advanced, offering continuous monitoring of various health metrics like heart rate and glucose levels. These devices empower individuals to take control of their health by facilitating early detection of potential issues, which is critical for timely intervention. The integration of wearables with healthcare systems enables real-time data sharing, enhancing personalized care.

Innovations in healthcare technology are essential for advancing the global preventive healthcare technologies and services market by enhancing access to care, improving diagnostic accuracy, empowering patients through wearable devices, and facilitating personalized interventions via AI and predictive analytics. These developments represent a transformative approach to health management that prioritizes prevention and proactive care strategies.

Furthermore, key players in the industry have innovative launches and government initiatives that would drive this global preventive healthcare technologies and services market growth. For instance, in December 2024, NURA, a joint venture between Fujifilm Healthcare and Dr. Kutty's Healthcare, launched its first AI-driven health screening center in Calicut, Kerala. This facility marks a significant step in NURA's strategic expansion into the Indian healthcare market, aiming to improve early disease detection capabilities. The center is designed to screen up to 50 individuals daily, focusing on the detection of cancer and metabolic syndromes, with plans to include screenings for locomotive syndrome in the future.

Also, in November 2024, Fujitsu announced the development of Policy Twin, an innovative digital twin technology designed to simulate the social impact of local government policies. This innovative tool aims to enhance the effectiveness of municipal preventive healthcare services by providing data-driven insights that enable policymakers to optimize their decisions. All these factors demand the global preventive healthcare technologies and services market. Moreover, the rising demand for the expansion of digital health solutions contributes to the global preventive healthcare technologies and services market expansion.

Data Security and Privacy Concerns

The data security and privacy concerns will hinder the growth of the global preventive healthcare technologies and services market. As preventive healthcare increasingly relies on digital platforms for personalized care, concerns about data security and patient privacy have escalated significantly. The reliance on technology for collecting and sharing sensitive patient information raises fears regarding unauthorized access, data breaches, and privacy violations. This growing apprehension has led to a notable distrust among consumers regarding healthcare organizations' ability to protect their data, potentially deterring individuals from utilizing preventive healthcare services.

For instance, according to the HIPAA Journal data stated that in 2024, the healthcare sector experienced a significant surge in data breaches, with 13 incidents involving more than 1 million healthcare records each. Among these incidents, the Change Healthcare breach emerged as the largest healthcare data breach in history, impacting nearly 190 million individuals. This incident highlights the critical vulnerabilities in healthcare data security and underscores the escalating threat of cyberattacks within the sector. Thus, the above factors could be limiting the global preventive healthcare technologies and services market's potential growth.

Segment Analysis

The global preventive healthcare technologies and services market is segmented based on technology type, service type, application, end-user, and region.

Technology Type:

The early detection and screening technologies segment is expected to dominate the global preventive healthcare technologies and services market share

The early detection and screening technologies segment holds a major portion of the global preventive healthcare technologies and services market share and is expected to continue to hold a significant portion of the global preventive healthcare technologies and services market share during the forecast period.

Early detection and screening technologies are critical for proactive healthcare management, enabling timely interventions that can significantly improve patient outcomes. These technologies assist in identifying diseases at an early stage when they are often more treatable, thereby reducing morbidity and mortality rates associated with conditions like cancer. This segment includes a range of advanced technologies and methodologies aimed at facilitating early diagnosis, particularly for chronic diseases and cancers.

Key Technologies in Early Detection and Screening include X-ray, CT, MRI, and Ultrasound. These imaging modalities are fundamental in detecting abnormalities within the body. X-rays are widely used to identify bone fractures and certain lung conditions. CT (Computed Tomography) scans provide detailed cross-sectional images of organs, aiding in the early detection of tumors.MRI (Magnetic Resonance Imaging) is particularly effective for soft tissue evaluation, making it invaluable in diagnosing conditions like brain tumors or joint disorders.

Ultrasound is often utilized for prenatal screenings and examining soft tissues. Genetic testing allows for the identification of inherited conditions that may predispose individuals to certain diseases, such as breast or colon cancer. Biomarkers serve as measurable indicators of biological processes or conditions. Tests that analyze blood or other bodily fluids to detect biomarkers can indicate the presence of diseases like cancer or diabetes before symptoms manifest.

Furthermore, key players in the industry initiatives and introducing awareness programs would propel this segment's growth in the global preventive healthcare technologies and services market. For instance, in February 2024, the National Institutes of Health (NIH) established the Cancer Screening Research Network (CSRN), a clinical trials network dedicated to evaluating new technologies for cancer screening. This initiative is part of the Biden-Harris administration's Cancer Moonshot, which aims to improve early cancer detection when treatment is often more effective. The CSRN will investigate methods to identify cancers at earlier stages, enhancing the potential for successful treatment outcomes.

Also, in December 2024, Apollo Cancer Centre introduced the LungLife Screening Program, a pioneering initiative aimed at the early detection of lung cancer through advanced low-dose computed tomography (LDCT) technology. This program is designed to identify high-risk individuals at an early stage, significantly improving the chances of successful treatment. These factors have solidified the segment's position in the global preventive healthcare technologies and services market.

Geographical Analysis

North America is expected to hold a significant position in the global preventive healthcare technologies and services market share

North America holds a substantial position in the global preventive healthcare technologies and services market and is expected to hold most of the market share.

The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and obesity is a significant driver of market growth. According to the Centers for Disease Control and Prevention (CDC), approximately 60% of adults in the U.S. have a chronic illness, with 40% having two or more conditions. This escalating burden necessitates effective preventive healthcare measures to manage these diseases proactively.

The aging population in North America significantly contributes to the demand for preventive healthcare services. By 2030, all baby boomers will be over the age of 65, which leads to an increased focus on preventive measures aimed at enhancing quality of life and managing age-related health issues.

Continuous innovations in healthcare technologies-including telehealth, mobile health applications, and advanced diagnostic tools (such as AI-driven imaging and genomic testing)-enhance the effectiveness and accessibility of preventive healthcare services. These advancements facilitate earlier disease detection and better management of chronic conditions.

Furthermore, in this region a major of kay players' presence, well-advanced healthcare infrastructure, investments, and awareness campaigns would drive this global preventive healthcare technologies and services market. For instance, in May 2024, Superpower, a healthcare platform dedicated to personalized and preventative medicine, successfully secured $4 million in pre-seed funding to launch its innovative platform focused on enhancing longevity-oriented healthcare in India. This virtual platform aims to simplify access for individuals seeking tailored health solutions that emphasize prevention and overall well-being.

Also, in February 2024, Henry Schein, Inc. launched the Prevention is Power campaign, a multi-year public health awareness initiative led by the Henry Schein Cares Foundation (HSCF). This campaign aims to enhance health literacy and encourage patients to engage with integrated preventive care, ultimately targeting a reduction in chronic disease prevalence and overall healthcare costs. Thus, the above factors are consolidating the region's position as a dominant force in the global preventive healthcare technologies and services market.

Asia Pacific is growing at the fastest pace in the global preventive healthcare technologies and services market share

Asia Pacific holds the fastest pace in the global preventive healthcare technologies and services market and is expected to hold most of the market share.

The rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory conditions significantly drives market growth in the APAC region. As lifestyles become more sedentary and dietary habits shift, the incidence of these diseases is increasing, necessitating effective preventive healthcare measures to manage these conditions proactively.

There is a notable increase in health awareness among consumers across APAC countries. Public health campaigns, educational initiatives, and improved access to information motivate individuals to engage in preventive healthcare practices, including regular screenings and vaccinations. This heightened awareness is crucial for fostering a culture of health and wellness.

Many governments in the APAC region are implementing policies aimed at promoting preventive healthcare. Initiatives targeting non-communicable diseases (NCDs) and funding for public health programs encourage the adoption of preventive services across various demographics, including remote areas.

Continuous advancements in healthcare technologies-including telehealth solutions, mobile health applications, and advanced diagnostic tools-enhance the accessibility and effectiveness of preventive healthcare services. These innovations enable earlier detection of diseases and better management of chronic conditions, making preventive care more efficient and user-friendly.

Furthermore, key player's strategies such as partnerships & collaborations, and innovative launches would drive this global preventive healthcare technologies and services market growth. For instance, in July 2024, Nervfit and MyCLNQ announced a strategic partnership aimed at enhancing technology-driven preventive healthcare in India. This collaboration will introduce an innovative system known as 'Technology-Enabled Care' (TEC), which merges Nervfit's expertise in wearable fitness technology with MyCLNQ's advanced health monitoring capabilities.

Also, in November 2024, Star Health Insurance, a leading health insurance provider in India, launched an innovative Corporate Social Responsibility (CSR) initiative called 'Star Arogya Digi Seva' in partnership with the Center for Chronic Disease and Control (CCDC). This innovative program aims to transform healthcare delivery in underserved communities by integrating telemedicine technology with Mobile Health Units (MHUs). Thus, the above factors are consolidating the region's position as the fastest-growing force in the global preventive healthcare technologies and services market.

Competitive Landscape

The major global players in the preventive healthcare technologies and services market include Medtronic, Myriad Genetics, Inc., Abbott., Quest Diagnostics., Merck & Co., Inc., GSK plc., Omnicell, McKesson Corporation, OMRON Healthcare, Pfizer Inc., and Sanofi among others.

Key Developments

  • In January 2025, Apollo ProHealth partnered with The Hindu to launch a new initiative aimed at providing the public with actionable health insights. This program is designed to enhance early awareness of health issues and empower individuals to make informed decisions regarding their health. By focusing on preventive measures, the initiative seeks to encourage proactive health management, enabling people to recognize potential health risks and take appropriate actions to mitigate them.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global preventive healthcare technologies and services market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Technology Type
  • 3.2. Snippet by Service Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in Healthcare Technology
    • 4.1.2. Restraints
      • 4.1.2.1. Data Security and Privacy Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Technology Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 6.1.2. Market Attractiveness Index, By Technology Type
  • 6.2. Early Detection and Screening Technologies*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Diagnostic Imaging
    • 6.2.4. Genetic Testing
    • 6.2.5. Biomarker Testing
    • 6.2.6. Others
  • 6.3. Chronic Disease Management Technologies
    • 6.3.1. Telehealth Services
    • 6.3.2. Remote Monitoring Tools
    • 6.3.3. Mobile Health Applications
    • 6.3.4. Others
  • 6.4. Vaccines
    • 6.4.1. Preventive Vaccines
    • 6.4.2. Therapeutic Vaccines
  • 6.5. Advanced Technologies
    • 6.5.1. Clinical Decision Support Systems (CDSS)
    • 6.5.2. Medication Management Systems
    • 6.5.3. Electronic Health Records (EHR) Systems
    • 6.5.4. Others

7. By Service Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 7.1.2. Market Attractiveness Index, By Service Type
  • 7.2. Wellness Programs*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Diagnostic Services
  • 7.4. Patient Education Services
  • 7.5. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cancer Prevention and Screening*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Infectious Disease Prevention
  • 8.4. Cardiovascular Disease Management
  • 8.5. Diabetes Management
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Healthcare Providers*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Healthcare Payers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Myriad Genetics, Inc.
  • 12.3. Abbott.
  • 12.4. Quest Diagnostics.
  • 12.5. Merck & Co., Inc.,
  • 12.6. GSK plc.
  • 12.7. Omnicell
  • 12.8. McKesson Corporation
  • 12.9. OMRON Healthcare
  • 12.10. Pfizer Inc.
  • 12.11. Sanofi

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us